Recurrent pityriasis rosea: A case report

Abstract

Pityriasis rosea is a papulosquamous skin disorder that occurs most commonly between the ages of 10 and 35 years. Recurrent pityriasis rosea is rare. We report a patient suffering from recurrent pityriasis rosea, whose etiology may be related to either vaccine-induced stimulation of the immune system, or some rare vaccine component(influenza A [H1N1] vaccine, hepatitis B vaccine). We believe that such a case is unique and it has not been reported previously. The patient was successfully treated with a combination of oral cetirizine, a topical steroid cream, and narrowband-ultraviolet B phototherapy. The symptoms of this disorder should be recognized by dermatologists.

Isolation of Mayaro Virus from a Venezuelan Patient with Febrile Illness, Arthralgias, and Rash: Further Evidence of Regional Strain Circulation and Possible Long-Term Endemicity

“…33,34 Although we lack biopsy confirmation of the diagnosis, our observations suggest that MAYV can trigger a psoriasiform dermatosis clinically mimicking pityriasis rosea, an acute, self-limiting papulosquamous skin disorder, which has been linked to endogenous systemic reactivation of human herpesvirus (HHV)-6 and/or HHV-7 and also to virus and vaccine-induced (influenza A [H1N1], hepatitis B-mediated) reactions. 35,36 Although MAYV was present in Barquisimeto, we did not see evidence of a major MAYV epidemic: in culturing more than 50 samples from patients with acute undifferentiated febrile illness during this time period, we identified only one MAYV case. Given that the patient had no history of recent travel outside of Barquisimeto, findings would be consistent with low-level transmission and possible endemicity within the city.…”

Pityriasis Rosea Recurrence is Much Higher than Previously Known: A Prospective Study

“…The aetiology of PR has not yet been fully elucidated. Due to its seasonal predominance and epidemic incidence in the community, viral, bacterial and fungal infective agents are considered to be responsible for this papulosquamous disease, but non-infective aetiologic agents, such as atopy, autoimmunity and certain drugs have also been implicated (10,11).…”

“…PR has attracted the attention of researchers since it was first reported in detail by Halkier-Sørensen in 1990 (12). Although the reason for the recurrences is not yet fully understood, there are some reports demonstrating PR recurrence after an upper respiratory tract infection, hepatitis B and influenza A (H1N1) vaccines, and HHV6 and 7 reactivation (10,13,14).…”

Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine

“…8 There is a paucity of reports describing pityriasis rosea associated with the influenza vaccine, hepatitis B vaccine, and human papillomavirus vaccine. 3 In such cases, the onset of skin lesions was thought to be related to vaccine-induced stimulation of the immune system or a component of the vaccine.…”

“…2 Pityriasis rosea also has been reported following the administration of new medications and vaccinations. [1][2][3] We report a case of a 30-year-old woman who developed pityriasis rosea 3 days after receiving the second dose of the COVID-19 vaccine.…”